Long-COVID symptoms improved after MDMA and psilocybin therapy: A case report.

Harman ChopraTim FurnishMonica Verduzco-GutierrezDavid S JevotovskyJoel Castellanos

Published in: Clinical case reports (2024)

Long-COVID, a syndrome persisting after the acute phase of coronavirus disease 2019 (COVID-19), lacks effective holistic treatment options. We present a case of a 41-year-old fully vaccinated female with Long-COVID syndrome who obtained significant symptomatic relief by self-prescribing psilocybin and MDMA. Future research is needed to assess safety and efficacy.

Keyphrases

coronavirus disease
sars cov
respiratory syndrome coronavirus
case report
stem cells
bone marrow
sleep quality